How to make a rodent giant: Genomic basis and tradeoffs of gigantism in the capybara, the world\u27s largest rodent by Herrera-Alvarez, Santiago et al.
University of Massachusetts Medical School 
eScholarship@UMMS 
University of Massachusetts Medical School Faculty Publications 
2020-11-10 
How to make a rodent giant: Genomic basis and tradeoffs of 
gigantism in the capybara, the world's largest rodent 
Santiago Herrera-Alvarez 
University of The Andes 
Et al. 
Let us know how access to this document benefits you. 
Follow this and additional works at: https://escholarship.umassmed.edu/faculty_pubs 
 Part of the Ecology and Evolutionary Biology Commons, and the Genetics and Genomics Commons 
Repository Citation 
Herrera-Alvarez S, Karlsson EK, Ryder OA, Lindblad-Toh K, Crawford AJ. (2020). How to make a rodent 
giant: Genomic basis and tradeoffs of gigantism in the capybara, the world's largest rodent. University of 
Massachusetts Medical School Faculty Publications. https://doi.org/10.1093/molbev/msaa285. 
Retrieved from https://escholarship.umassmed.edu/faculty_pubs/1903 
Creative Commons License 
This work is licensed under a Creative Commons Attribution-Noncommercial 4.0 License 
This material is brought to you by eScholarship@UMMS. It has been accepted for inclusion in University of 
Massachusetts Medical School Faculty Publications by an authorized administrator of eScholarship@UMMS. For 
more information, please contact Lisa.Palmer@umassmed.edu. 
How to Make a Rodent Giant: Genomic Basis and Tradeoffs of
Gigantism in the Capybara, the World’s Largest Rodent
Santiago Herrera-Alvarez,*†,1 Elinor Karlsson,2,3 Oliver A. Ryder,4 Kerstin Lindblad-Toh,2,5 and
Andrew J. Crawford1
1Department of Biological Sciences, Universidad de Los Andes, Bogota, Colombia
2Broad Institute of MIT and Harvard, Cambridge, MA, USA
3Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, USA
4San Diego Zoo Institute for Conservation Research, San Diego Zoo Global, Escondido, CA, USA
5Science for Life Laboratory, Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden
†Present address: Department of Ecology & Evolution, University of Chicago, Chicago, IL, USA
*Corresponding author: E-mail: sherrera2@uchicago.edu.
Associate editor: Rebekah Rogers
Abstract
Gigantism results when one lineage within a clade evolves extremely large body size relative to its small-bodied ancestors,
a common phenomenon in animals. Theory predicts that the evolution of giants should be constrained by two tradeoffs.
First, because body size is negatively correlated with population size, purifying selection is expected to be less efficient in
species of large body size, leading to increased mutational load. Second, gigantism is achieved through generating a
higher number of cells along with higher rates of cell proliferation, thus increasing the likelihood of cancer. To explore the
genetic basis of gigantism in rodents and uncover genomic signatures of gigantism-related tradeoffs, we assembled a draft
genome of the capybara (Hydrochoerus hydrochaeris), the world’s largest living rodent. We found that the genome-wide
ratio of nonsynonymous to synonymous mutations (x) is elevated in the capybara relative to other rodents, likely caused
by a generation-time effect and consistent with a nearly neutral model of molecular evolution. A genome-wide scan for
adaptive protein evolution in the capybara highlighted several genes controlling postnatal bone growth regulation and
musculoskeletal development, which are relevant to anatomical and developmental modifications for an increase in
overall body size. Capybara-specific gene-family expansions included a putative novel anticancer adaptation that involves
T-cell-mediated tumor suppression, offering a potential resolution to the increased cancer risk in this lineage. Our
comparative genomic results uncovered the signature of an intragenomic conflict where the evolution of gigantism in
the capybara involved selection on genes and pathways that are directly linked to cancer.
Key words: gigantism, capybara, cancer, comparative genomics.
Introduction
Body size is arguably the most apparent characteristic when
studying multicellular life, and understanding how and why
body size evolves has been a major question in biology
(Haldane 1927; Bonner 1968). Body size is a canonical com-
plex trait, and, consequently, ontogenetic changes underlying
body size evolution directly impact other life-history traits,
such as fecundity and longevity (Calder 1984; Shingleton
2011). Yet, the genetic and developmental bases of size var-
iation among species are not well understood for most line-
ages. Although increase in body size likely has several selective
advantages (Purvis and Orme 2005), maximum body size in
tetrapods appears to be determined mostly by intrinsic bio-
logical constraints (McNeill Alexander 1998; Kozlowski and
Gawelczyk 2002; Sookias et al. 2012). Two major costs to the
evolution of large bodies are the reduction in population size,
which may increase extinction risk, and the increased risk of
developing growth-associated diseases, such as cancer
(Damuth 1981; Caulin and Maley 2011).
Not only do larger species have lower population densities
(Damuth 1981), they also show slower metabolic rates, longer
generation times, and a reduced reproductive output (Calder
1984). Together these traits lead to an overall reduction in the
genetic effective population size (Ne) relative to small-bodied
species (Leffler et al. 2012). In a finite population, the interplay
between selection and genetic drift determines the fate of
newly arisen mutations, and the strength of drift relative to
selection will largely depend on Ne (Charlesworth 2009). In
smaller populations, slightly deleterious mutations are
expected to accumulate at a higher rate than in larger pop-
ulations, due to stronger genetic drift relative to purifying
selection, thus increasing the mutation load in the popula-
tion, which may further increase the risk of extinction (Lynch
and Gabriel 1990). In addition, animals show positive
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allometric scaling of number of cells in the body with overall
body size (Savage et al. 2007), that is, animals evolve large
body size mainly by increasing cell numbers not cell sizes.
Thus, if every cell has an equal probability, however low, of
becoming cancerous, and related species have equivalent can-
cer suppression mechanisms, the risk of developing cancer
should increase as a function of the number of cells.
Therefore, large species should face a higher lifetime risk of
cancer simply because large bodies contain more cells (Caulin
and Maley 2011; Tollis et al. 2017). Moreover, giant body sizes
are achieved mainly by an accelerated postnatal growth rate
(Erickson et al. 2001), which represents an increment in cell
proliferation rates, as well (Lui and Baron 2011). For a given
mutation rate, an elevated rate of cell proliferation accelerates
the rate of mutation accumulation and, thus, increases the
chances for a cell population of becoming cancerous (Cairns
1975).
The continued existence of enormous animals, such as
whales and elephants, implies, however, that the evolution
of gigantism must be coupled with the evolution of cancer
suppression mechanisms. The lack of correlation between size
and cancer incidence is known as Peto’s Paradox and suggests
that large-sized species have mitigated the inherent increase
in cancer risk associated with the evolution of large bodies
(Caulin and Maley 2011; Tollis et al. 2017). For instance,
genomes of two of the largest living groups of mammals,
proboscideans (Asian and African elephants) and cetaceans
(whales and dolphins), revealed lineage-specific expansion of
genes associated with tumor suppression via enhanced DNA-
damage response (Sulak et al. 2016; Vazquez et al. 2018) and
positive selection in cell-cycle control pathways (Tollis et al.
2019), respectively. These genomic changes likely evolved in
response to cancer selection, that is, selection to prevent or
postpone deaths by cancer at least until after reaching repro-
ductive maturity. Such changes might account for the relative
lower incidence of cancer in large animals and the evolution
of anticancer mechanisms (Leroi et al. 2002).
Among mammals, rodents are the most diverse group in
terms of species richness and morphological disparity, partic-
ularly in body size. South American rodents of the infraorder
Caviomorpha represent one of the most spectacular evolu-
tionary radiations among living New World mammals
(Hershkovitz 1972), and fossil data suggest the independent
evolution of gigantism in at least three lineages (Vucetich and
Deschamps 2015). Caviomorphs have the broadest range in
body size within rodents, and make Rodentia one of the
mammalian orders with the largest range in body size
(Sanchez-Villagra et al. 2003). Most notable among the cav-
iomorphs is the largest living rodent, the capybara,
Hydrochoerus hydrochaeris (Linnaeus, 1776), family Caviidae
(fig. 1C). Capybaras have an average adult body weight of
55 kg (Nowak and Paradiso 1983), being 60 times more mas-
sive than their closest living relative, the rock cavies (Kerodon
sp.). Overall, capybaras are 3 orders of magnitude above the
mean body size for the order and2,000 times more massive
than the common mouse, Mus musculus (Nowak and
Paradiso 1983). Previous studies of physiology and molecular
evolution showed that caviomorph insulin, a hormone in-
volved in growth and metabolism, has a higher mitogenic
effect relative to other mammalian growth factors (King
and Kahn 1981; Opazo et al. 2005), suggesting that lineage-
specific changes in insulin within caviomorphs may coincide
with important changes in life-history traits. However, the
genomic basis of the capybara’s unique size remains unex-
plored. Additionally, there is evidence that telomerase activity
has coevolved with body mass in rodents, with the largest
species (i.e., capybara and beaver) displaying low telomerase
activity in somatic tissues, suggesting a potential role for rep-
licative senescence as a cancer suppression mechanism in
large-bodied rodents (Seluanov et al. 2007).
Here we investigate 1) whether there is genomic evidence
of demographic processes precipitating a genome-wide cost
to evolving a large body size, 2) the genetic factors underlying
the evolution of capybara’s giant body size, 3) whether cap-
ybara has a unique solution to its increased risk of cancer
relative to smaller rodents, and 4) the relationship between
growth-regulatory pathways and cancer during the evolution
of gigantism.
Results
Genome Assembly and Annotation
We generated a whole-genome sequence and de novo as-
sembly of a female capybara, using a combination of a
DISCOVAR de novo assembly and Chicago libraries (see
Materials and Methods). The total length of the assembly
was 2.73 Gb, slightly shorter than the genome size estimated
by flow cytometry of 3.14 Gb (table 1), including 73,920 con-
tigs with an N50 of 12.2 Mb and the longest contig at 75.7 Mb.
The GC content was estimated at 39.79%.
Our capybara assembly had very high coverage of coding
regions: We recovered 89% of the 3,023 vertebrate
Benchmarking Universal Single-Copy Orthologs (BUSCO
pipeline; Sim~ao et al. 2015), and 94.4% of the ultraconserved
core eukaryotic genes (CEGMA pipeline; Parra et al. 2007),
which is comparable to the guinea pig genome despite the
latter having 2-fold larger scaffold N50 (supplementary fig.
S1A). We used guinea pig, rat, and mouse Ensembl protein
sets to guide the homology-based annotation with MAKER
v2.31.9 (Cantarel et al. 2007), resulting in a capybara genome
containing 24,941 protein-coding genes with 92.5% of the
annotations with an annotation edit distance (AED) below
0.5 (see Materials and Methods). RepeatMasker annotation
and classification of repetitive elements estimated that 37.4%
of the capybara genome corresponded to repetitive content,
spanning 1,025 Mb of the genome (supplementary fig. S1B).
Most of the repeat content (72.5%) corresponded to trans-
posable elements, with LINE-1 the most abundant (20.46%),
similar to the mouse genome (Waterston et al. 2002). Further
comparison across the rodent phylogeny showed that both
genome size and repeat content of the capybara are compa-
rable to that of other rodents (fig. 1B).
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The Little Giants: Phylogenetic Analysis of Body Mass
Evolution
To determine whether the capybara could be considered a
giant based on a lineage-specific accelerated rate of body mass
evolution, we used phylogenetic comparative methods. We
found that the rate of body mass evolution among cavio-
morph rodents has not been constant throughout their phy-
logenetic history, as shown by the better fit of a multirate
model compared with the single-rate-Brownian Motion
model (DDIC ¼ 78.6; supplementary table S1) with an esti-
mated value of a¼ 1.35 (95% confidence interval [CI] of 1.0–
1.7). The ancestral body size of the most recent common
ancestor (MRCA) of Caviomorpha was estimated to be
971 g (95% CI: 221–5,135 g) and the size of the MRCA of
the capybara and rock cavy (Kerodon rupestris) was estimated
to be 1,132 g (95% CI: 437–23,225 g), suggesting that the rate
of body size evolution has undergone one or more sudden
changes.
Using the AUTEUR package (Eastman et al. 2011), we in-
ferred three shifts in the rate of body-mass evolution along
the caviomorph tree (supplementary fig. S4): one decrease in
evolutionary rate at the root of the Octodontoidea clade
(shift probability of 0.11), and two incidences of rate acceler-
ation. The first rate increase was localized on the branch
leading to the coypu (Myocastor coypus; shift probability of
0.16), the largest species within Octodontoidea, and a second
increase, with the highest posterior support (shift probability
of 0.44), in the MRCA of the capybara, rock cavy, and
Patagonian mara (Dolichotis patagonum). Capybaras and
Patagonian maras are the largest living species of caviomorph
rodents, yet the capybara is approximately three times
heavier (supplementary fig. S5). These results suggest that
the capybara evolved from a moderately small ancestor, com-
parable to the size of a guinea pig, indicating that capybara’s
characteristic large body size was achieved by a spurt in the
rate of body mass evolution (see also Alvarez et al. 2017).
The accelerated rate of body mass evolution observed in
capybaras relative to other rodents parallels the rate acceler-
ation observed in the world’s largest animals, for example,
elephants, the largest living terrestrial mammals relative to







Total length (Mb) 2,735 2,738
Contig N50 (kb) 148 161
Number of scaffolds 656,018 73,920
Scaffold N50 (Mb) 0.202 12.2
FIG. 1. Divergence times, genome assembly statistics and body mass of representative rodents used for comparative genomics analyses. (A)
Divergence times of rodent species using the topology obtained from the phylogenomic analysis (see Materials and Methods). Ma, million years
ago. (B) Basic genome assembly statistics of rodent species included in comparative analyses. Repeat content and gene content were unavailable
for deer mouse and marmot. (C) Body mass ranges from 20.5 g for the mouse to 55,000 g in the capybara, the largest living rodent.
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their much smaller afrotherian ancestors (Puttick and
Thomas 2015), baleen whales including the blue whale, the
largest animal to have ever lived, relative to ancestral mysti-
cetes (Slater et al. 2017), and sauropodomorphs, the largest
terrestrial animals in Earth history, relative to other dinosaurs
(Benson et al. 2014). Thus, the tempo and mode of body size
evolution in rodents demonstrates that the capybara also
provides an example of gigantism.
Having characterized the genome and the mode of body
mass evolution, we undertook detailed analyses of key genes
and gene families to explore the genomic basis of the capy-
bara’s large size, identified possible molecular adaptations re-
lated to cancer suppression, and detected the genomic
signatures associated with a reduced Ne.
Body Size, Ne, Generation Time, and Genome-Wide
Substitution Rates
We tested the hypothesis that larger species should harbor a
higher number of slightly deleterious mutations, that is, mu-
tation load, as a result of a reduction in population size. Under
the simplifying assumption that synonymous mutations are
neutral, the ratio of nonsynonymous substitutions to synon-
ymous substitutions (dN/dS, or x) can be also thought of as a
measure of the strength of purifying selection over evolution-
ary time >4Ne generations (Elyashiv et al. 2010). Therefore,
genome-wide (as opposed to gene-specific) inflation of x
indicates a reduction in the efficacy of purifying selection
and thus a potential increase in the mutation load (Figuet
et al. 2016). Because the strength of purifying selection relative
to drift is lower in smaller populations (Ohta 1992; Popadin
et al. 2007), and body mass is negatively correlated with pop-
ulation size (Damuth 1981), we expected a genome-wide in-
crease in x in the capybara relative to smaller rodents. To
explore this prediction, we used body mass for each of 15
rodent species with available genome assemblies (fig. 1) as a
proxy for Ne, and median genome-wide x values across 229
single-copy gene orthologs (SCOs) as measure of the genetic
load. We found that the median genome-wide x in the cap-
ybara is higher relative to the rest of rodents (0.0964 and
0.0674, respectively; permutation test P-value < 0.001, ta-
ble 2). Upon closer inspection, however, we found that the
genome-wide median dN in capybara was similar to the rest of
rodents (0.0063 vs. 0.0069, respectively; permutation test P-
value > 0.1; table 2), thus the higher genome-wide x in
capybara was actually caused by its significantly lower median
dS (0.065 vs. 0.108, respectively; permutation test P-value <
0.0001; table 2). A closer comparison between the capybara
and guinea pig showed that this pattern was not likely af-
fected by differences in GC composition among the genes or
between species (supplementary fig. S6). Further, body mass
showed a weak negative correlation with dS, but no correla-
tion with dN values among rodents (fig. 2C). A lower genome-
wide median dS could be caused by a generation-time effect
(GTE), where longer generation times can lead to slower rates
of neutral evolution per unit time (Ohta 1993; Chao and Carr
1993). Consistent with this hypothesis, body mass and
Table 2. Median Values for Each Substitution Rate Class between
Capybara and the Rest of Rodents across 229 SCOs.
x dN dS
Capybara 0.0964 0.006 0.065
Other rodents 0.0674 0.006 0.108
P-value* <0.001 0.246 <0.0001
*P-values are based on permutation tests. The elevated x value observed in the
capybara is caused by an overall lower synonymous substitution rate (dS) relative to
the rest of rodents consistent with a GTE.
FIG. 2. Generation-time effect on rates of molecular evolution among rodent genomes. (A) Correlation of body size and generation time among
rodents (Phylogenetic Independent Contrasts (PIC): Spearman’s r ¼ 0.535, P-value < 0.05). (B) Regression of log-transformed body mass values
with genome-wide median w for each rodent species, excluding the naked mole rat, based on values for 229 SCOs (see text for details; PIC: R2¼
0.563, df ¼ 12, P-value < 0.01). (C) Regression of log-transformed body mass values with genome-wide median w for each rodent species
partitioned into dN and dS, excluding the naked mole rat, based on values for 229 SCOs (dS: effect ¼0.0094, df ¼ 13, P-value > 0.05; dN: effect
¼ 0.0, df ¼ 13, P-value > 0.05).
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generation time were positively correlated across rodents
(fig. 2A).
The naked mole rat (Heterocephalus glaber) had the high-
est genome-wide median x of 0.105, much higher than the
expected value according to its body mass and generation
time in the model (supplementary fig. S7; outlier based on
standardized residuals analysis), suggesting that interspecific
variation in x is influenced by additional factors not related
to the GTE. Previous studies showed evidence that a subter-
ranean lifestyle and eusosociality (both present in H. glaber)
are factors that further reduce Ne leading to a reduction of
genetic diversity and an increase in mutation load (Romiguier
et al. 2014; Visser et al. 2018), which may explain the inflation
of x in this species. In fact, the proportion of variation in
genome-wide median x that is explained by body mass (R2)
increases from 0.28 to 0.56 when the naked mole rat is left
outside the analysis (fig. 2B). Additionally, we estimated x
values for the 13 protein-coding mitochondrial genes in ten
rodent species (supplementary table S3) and found that the
capybara and naked mole rat present higher than average
median x values for both genomes, confirming our hypoth-
esis of an independent reduction in Ne in both species (sup-
plementary fig. S7). Although the capybara does not harbor a
net higher number of fixed nonsynonymous substitutions, as
is expected for mutation load, the decoupling of dN and dS
values with size, and the constancy of dN values across all
rodent species suggests that there is an elevated proportion of
fixed nonsynonymous substitutions relative to the neutral
expectation as body size increases. Taken together, these
results provide evidence consistent with a nearly neutral
model of molecular evolution among rodent species and
support the existence of a GTE in the capybara linked to
the evolution of its large size.
Gene-Specific Rates of Evolution in the Capybara Are
Linked to Cellular, Metabolic, and Developmental
Pathways Related to Growth
The distribution of estimated x values for the 229 SCOs (see
Materials and Methods) in the capybara was bimodal, with a
left peak centered at x ¼ 0.09 (N¼ 193 genes), and a right
peak at x ¼ 0.52 (N¼ 33 genes; supplementary fig. S6A),
whereas the combined distribution of x values for the rest
of rodents was unimodal and centered at x ¼ 0.06. A Gene
Ontology (GO) enrichment test of these 33 high-x genes in
the capybara showed an overrepresentation of 22 GOSlim
categories (out of 122; P-values < 0.05 after Bonferroni cor-
rection) that mainly included metabolic processes such as
oxidoreductase activity, generation of precursor metabolites
and energy, small molecule metabolic process, and cofactor
metabolic process, among others. Additionally, these 33 genes
had significantly higher median dN compared with the genes
in the left peak (0.03 vs. 0.006, respectively; Welch’s two sam-
ple t-test, t¼ 7.18, df¼ 33.31, P-value < 0.0001) but did not
differ significantly in median dS. Taken together, these results
suggest that a shift possibly related to an increase in basal
metabolic rate, which has been associated with an increase in
body size (White and Seymour 2003), may be causing the
bimodal distribution in the capybara.
In order to identify genes related to gigantism and cancer
resistance, we performed an analysis of positive selection on
the capybara lineage using codon-based models of evolution
(Yang 2007; Smith et al. 2015) that take into account hetero-
geneous selection pressure at different sites within proteins,
combined with a protein sequence-divergence approach (see
Materials and Methods). We identified a set of 4,452 SCOs
between five available genomes of hystricognath rodents: na-
ked mole rat, degu (Octodon degus), chinchilla (Chinchilla
lanigera), guinea pig, and capybara (fig. 3 inset). We consid-
ered genes as positively selected in the capybara lineage when
they fell in the top 5% of fastest evolving genes as estimated
by both of two metrics, the likelihood ratios (LRs) of branch-
site models and the standardized protein distance index (PDI)
statistic of protein p-distance, resulting in 39 candidate genes
(fig. 3; supplementary fig. S13; see Materials and Methods).
The modest number of candidate genes is not surprising
given the low levels of protein divergence between capybara
and guinea pig (mean: 0.01, 95% CI: 0.009–0.012). Our ap-
proach using two filters yielded more conservative results
than filtering genes based on either the false discovery rate
or a Bonferroni correction of LR P-values (a ¼ 0.01), which
yielded a number of genes putatively under selection equal to
1,229 and 920, respectively. Thus, our approach narrows the
set of candidate genes by identifying the genes with the stron-
gest signals.
These 39 genes were enriched for 21 GOSlim categories,
including growth, embryo development, cell population pro-
liferation, and immune system process (fig. 3B shows specific
GO biological processes terms). Additionally, fast-evolving
genes in the capybara, among 8,084 SCOs shared by capy-
bara–guinea pig–rat, were enriched for 36 GOSlim categories,
including cell cycle, cell death, immune system process, mi-
totic cell cycle, and aging (Supplementary Material online).
Lastly, besides codon-based models of evolution and protein
distance methods, we identified conserved positions within
protein alignments that uniquely change in the capybara as a
proxy for changes in protein function (Jelier et al. 2011).
Proteins with high proportion of unique-capybara residues
were enriched for GO biological processes terms such as telo-
mere maintenance (GO:0000723) and growth plate cartilage
chondrocyte proliferation (GO:0003419; supplementary fig.
S11).
Gene Family Expansions and Functional Composition
of Capybara Genome
Gene family evolution, especially expansion by gene duplica-
tion, has been recognized as an important mechanism
explaining morphological and physiological differences be-
tween species (Demuth et al. 2006). To characterize the rep-
ertoires of gene functions of rodent genomes, we employed a
phenetic approach based on principal component analysis
(PCA) that seeks to quantify and visualize the similarity in
functional composition among species (see Materials and
Methods). The PCA largely reflected phylogenetic relation-
ships within Rodentia (fig. 4A), except for the capybara, which
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showed a clear signature of genome-wide functional expan-
sion relative to the rest of rodents. To explore which gene
families were driving this pattern, we performed an overrep-
resentation test to determine the gene families that domi-
nated the loadings of each principal component. The main
determinants of PC1 were the expansion of gene families
related to sensory perception of smell, G-protein-coupled
receptor signaling and immune response (fig. 4A). Further,
based on a genome-wide screen of 14,825 gene families pre-
sent in at least 15 of 16 genomes, we identified 39 families
significantly expanded, and one family significantly con-
tracted in the capybara (supplementary fig. S9).
Evolution of Developmental Regulators of Growth
and Size
Our comparative genomic results pointed to a number of
genes and gene families within the insulin/insulin-like growth
factor signaling (IIS) and transforming growth factor-b signal-
ing (TGFbS) pathways exhibiting signatures of either acceler-
ated evolution and positive selection, or gene family
expansion in the capybara (figs. 3, 4B, 4C, and 5). The IIS
pathway is implicated in embryonic and postnatal growth
via cell proliferation (Baker et al. 1993). For instance, LEP
(leptin; x > 1 in pairwise comparison against guinea pig;
Supplementary Material online) is an important growth
factor that regulates body weight and bone mass through
the IIS pathway (Margetic et al. 2002). PLAGL2
(Pleiomorphic adenoma-like Protein 2; fig. 3A) is a member
of the PLAG family of zinc finger transcription factors, which
drives the expression of the insulin-like growth factor II (igf2)
activating the igf2-mitogenic signaling pathway (Hensen et al.
2002), and disruption can result in decreased body weight
and postnatal growth retardation in mice (Hensen et al. 2004;
Blake et al. 2017). IGF-II provides a constitutive drive for fetal
and postnatal growth (Fowden 2003) and it has been shown
that IGF-II levels do not drop after birth in caviomorph
rodents, but instead remain detectable in adulthood
(Levinovitz et al. 1992). PI3K signaling is implicated in cell
proliferation, growth, and survival via the IIS and mTOR sig-
naling pathways (Laplante and Sabatini 2012). PI3KR2
(Phosphatidylinositol 3-kinase Regulatory subunit b; fig. 4B)
has been shown to have both oncogenetic (Ito et al. 2014)
and tumor suppressor properties (Taniguchi et al. 2010), and
PRKCI (atypical protein kinase C isoform PRKC iota; fig. 4B)
functions downstream of PI3K and is involved in cell survival,
differentiation, and proliferation by accelerating G1/S transi-
tion (Ni et al. 2016). PDX1 (Pancreatic and duodenal homeo-
box 1; accelerated evolution relative to rat and guinea pig—
see Supplementary Material online) is an important transcrip-
tion factor that is crucial for establishing and maintaining the
A B
FIG. 3. Positively selected genes in the capybara. (A) Standardized PDI represents the corrected divergence in amino acid sequences in capybara
versus degu relative to the guinea pig (see Materials and Methods). LR branch-site test scores represent strength of evidence for positive selection
acting on specific residues within the capybara protein sequence relative to the other four hystricognath rodent species (see Materials and
Methods). Dark gray dots are genes that lie in the extreme 5% of both distributions (dotted lines) and are, thus, considered to be under positive
selection according to our two criteria. Among the 39 genes putatively under positive selection, eight were associated with body size regulation
(colored dots and arrows). PLAGL2, pleiomorphic adenoma-like protein 2; OSR1, odd skipped related transcription factor; ACVR1B, activin A
receptor 1B; DEAF1, deformed epidermal autoregulatory factor 1; BMPR1A, bone morphogenetic protein receptor 1A; SMAD6, mothers against DPP
homolog 6; TAPT1, transmembrane anterior posterior transformation 1; MEOX2, mesenchyme homeobox 2. Inset: Venn diagram of the protein
orthologous clusters among the five hystricognath species: capybara (Hydrochoerus hydrochaeris), guinea pig (Cavia porcellus), degu (Octodon
degus), chinchilla (Chinchilla lanigera), and naked mole rat (Heterocephalus glaber). Of the 12,878 orthologous groups shared by all five species,
4,452 were SCOs. (B) TreeMap from REVIGO for GO biological process terms present in the 39 genes evolving under positive selection in the
capybara. Rectangle size reflects semantic uniqueness of GO term, which measures the degree to which the term is an outlier when compared
semantically with the list of terms present in the mouse.
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functional identity of insulin-producing b-cells (Gao et al.
2014), and in adult b-cells it regulates insulin gene transcrip-
tion (Pagliuca and Melton 2013), an important growth factor
in caviomorphs (King and Kahn 1981).
The TGFbS pathway is crucial for regulation of cell growth,
differentiation and development (Wu and Hill 2009), and
TGFb/BMP-activated Smads are critical for the formation of
the skeleton during development (Chen et al. 2012). We
found several genes within this pathway to exhibit signatures
of positive selection (fig. 3A). For instance, SMAD6 (mothers
against DPP homolog 6) is an important inhibitor of BMP-
mediated effects on chondrocytes and is involved in endo-
chondral bone formation in axial and appendicular skeletal
development (Estrada et al. 2011; Chen et al. 2012). ACVR1B
(activin receptor type 1B) and BMPR1A (bone morphogenetic
protein receptor type 1A) are essential in endochondral bone
formation, promoting proliferation and differentiation of
chondrocytes and osteoblasts through BMP signaling espe-
cially during postnatal bone development (Lin et al. 2016).
TAPT1 (transmembrane anterior posterior transformation 1)
and DEAF1 (deformed epidermal autoregulatory factor 1) are
required for vertebrate axial skeletal patterning during devel-
opment through the regulation of Hox genes expression and
activity (Howell et al. 2007; Casaca et al. 2014). Further,
MEOX2 is essential in axial skeletal and limb muscular devel-




FIG. 4. Gene family composition analysis. (A) Clustering of rodent genomes in a multidimensional space of molecular functions. The first two
principal components are displayed, accounting for 20.14% and 11.34% of the variation, respectively. PC1 separates the capybara from the rest of
the rodents based on the enrichment of gene families related to sensory perception and immune response. HYST, Hystricognathi clade; MRC,
mouse-related clade; SRC, squirrel-related clade. Black portion of arrows indicates expansion of gene families within each PC. (B) Gene families
related to growth control and tumor suppression that showed a significant expansion in the capybara (P-value < 0.05). The heatmap shows
normalized gene counts of PANTHER molecular function categories for the 16 rodents. (C) Maximum likelihood phylogenetic tree of MAGEB5
gene family of capybara (24 MAGEB5 members) compared with rodents and rabbit, plus primate outgroups (human, gorilla, rhesus macaque, and
squirrel monkey). The yellow clade contains capybara and guinea pig members, whereas the orange clade shows a monophyletic expansion of
MAGEB5 genes in capybara. Bottom: Schematic representation of the organization of MAGEB5 copies throughout the capybara genome. Triangles
represent position and transcriptional direction of each copy (colors match clades on phylogeny), and the “//” represent different scaffolds. Hhyd,
Hydrochoerus hydrochaeris (capybara); Cpor, Cavia porcellus (guinea pig); Clan, Chinchilla lanigera (chinchilla); Odeg, Octodon degus (degu); Hgla,
Heterocephalus glaber (naked mole rat); Mmus, Mus musculus (mouse); Rnor, Rattus norvegicus (rat); Mocr, Microtus ochrogaster (vole); Maur,
Mesocricetus auratus (hamster); Pman, Peromyscus maniculatus (deer mouse); Ngal, Nannospalax galili (blind mole rat); Jjac, Jaculus jaculus
(jerboa); Dord, Dipodomys ordii (kangaroo rat); Ccan, Castor canadensis (beaver); Itri, Ictidomys tridecemlineatus (squirrel); Mmar, Marmota
marmota (marmot).
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expressed in the interdigital regions of limb buds (So and
Danielian 1999) suggesting a role in the formation of semi-
webbed feet in the capybara. Additionally, postnatal skeletal
duration of growth is controlled by the IIS pathway by main-
taining an active population of chondrocytes in the growth
plate, where IGF-II is essential for longitudinal and apposi-
tional postnatal bone growth in rodents (Uchimura et al.
2017). Overall, these results suggest that along with the
growth-related effects of caviomorph insulin (King and
Kahn 1981; Opazo et al. 2005), lineage-specific shifts in cell
proliferation, especially in relation to postnatal bone growth,
as well as axial skeletal and limb musculoskeletal develop-
ment may have been crucial for allowing the evolution of a
giant body size.
Growth Pathways Are Enriched in Cancer Pathways
Cancer places a major constraint on the evolution of large
bodies. How can giants evolve, or even exist, if size is regulated
through somatic growth and cancer appears through somatic
evolution (Conlon and Raff 1999; Crespi and Summers 2005)?
To investigate the relationship between growth and cancer
during the evolution of a giant body size in the capybara, we
used the genes that showed lineage-specific positive selection
and rapid evolution, high concentration of unique-capybara
residues, and capybara-expanded gene families (see above
and Supplementary Material online) to perform a network
analysis of 90 interacting genes using String Database (Mering
et al. 2003). Network analyses based on GO biological process
terms revealed seven functional clusters among the 90 genes
including immunity, regulation of cell proliferation, cell com-
munication and adhesion, metabolism and homeostasis, mi-
tochondrion organization and metabolism, neuronal
development, and ribosome maturation (fig. 6A).
We extracted 22 genes deeply involved in growth regula-
tion by the IIS/TGFbS pathways, and the T-cell-mediated
immunity pathway to explore in more detail the interaction
between growth and potential cancer suppression mecha-
nisms (fig. 6B). Remarkably, we found that this smaller net-
work has an enrichment of cancer pathways such as prostate
cancer (hsa05215), breast cancer (hsa05224), pathways in
cancer (hsa05200), and transcriptional misregulation in can-
cer (hsa05202), consistent with the roles of IIS and TGFbS
pathways in cell proliferation, growth, and survival in solid
tumors (Yuan and Cantley 2008; Wu and Hill 2009). For in-
stance, INS1, PI3KR2, PLAGL2, LEP, and SMAD6 have been
reported as not only growth factors, promoting somatic evo-
lution, but also oncogenes, enabling tumor progression
(fig. 6B). LEP promotes angiogenesis through VEGF signaling
and acts as an autocrine factor in cancer cells promoting
proliferation and inhibition of apoptosis (Ando and
Catalano 2012). PLAGL2 contributes to cancer by generating
loss of cell–cell contact inhibition, maintaining an immature
differentiation state in glioblastomas, and inducing prolifera-
tion of hematopoietic progenitors in leukemia (Hensen et al.
2002; Zheng et al. 2010; Landrette et al. 2011). PI3K signaling
nodes are some of the most common altered targets in solid
tumors (Yuan and Cantley 2008). Lastly, SMAD6 potentiates
invasion and aggressiveness of cells in breast cancer (De Boeck
et al. 2016). These observations suggest that some cancers
could arise as a by-product of growth regulatory evolution.
Evolution of a Putative Cancer Resistance Pathway
In rodents, cancer incidence has been reported to be 46% in a
wild-caught population of Mus musculus raised in the labo-
ratory (Andervont and Dunn 1962), and 14.4–30% in guinea
pigs older than 3 years (Jelınek 2003). If the capybara’s large
body size is caused by an increase in cell proliferation, this
could potentially lead to an increased risk of cancer. However,
in capybaras, only three cases of cancer have been reported to
date (Stoffregen et al. 1993; Hamano et al. 2014; Srivorakul
et al. 2017), suggesting the possibility of a lower incidence of
cancer in capybara relative to other rodents. If so, this pattern
would be consistent with empiric analyses of Peto’s Paradox
(Abegglen et al. 2015). Thus, we searched for genes and gene
families related to cancer resistance in the capybara.
Consistent with previous studies suggesting that telomere
shortening coevolves with body mass in rodents (Gorbunova
and Seluanov 2009), our analyses of positive selection and
unique-capybara residues identified genes involved in cellular
senescence (fig. 3B) and telomere maintenance, such as
TERF2IP (telomeric repeat-binding factor 2-interacting protein
1) which regulates telomere length in mammals (supplemen-
tary fig. S11). Additionally, we found three gene families sig-
nificantly expanded in the capybara relative to other rodents
related to tumor reversion and cancer suppression by the
immune system (fig. 4B and C; supplementary fig. S10),
namely TPT1 (tumor protein, translationally-controlled 1),
MAGEB5 (melanoma antigen family B5), and GZMB (gran-
zyme B). TPT1 has a major role in phenotypic reprogramming
of cells, inducing cell proliferation and growth via the mTOR
signaling pathway, and plays a role in tumor reversion where
cancer cells lose their malignant phenotype (Amson et al.
2013). Type I MAGE genes (e.g., MAGEB5) are expressed in
highly proliferating cells such as placenta, tumors, and germ-
line cells (van der Bruggen et al. 1991). In normal somatic
tissues these genes are deactivated but when cells become
neoplastic, MAGE genes are reactivated and the resultant
proteins may be recognized by cytotoxic T lymphocytes, trig-
gering a T-cell-mediated tumor suppression response (van
der Bruggen et al. 1991). Lastly, GZMB is an important com-
ponent of the perforin/granzyme-mediated cell-killing re-
sponse of cytotoxic T lymphocytes via caspase-dependent
apoptosis (Russell and Ley 2002). The fact that the capybara
displays functional expansion in the T-cell receptor signaling
pathway (fig. 4A), and expansion of MAGEB5 and GZMB
gene families, suggests that T-cell-mediated tumor suppres-
sion response may be a lineage-specific response to reduce
the increased cancer risk related to the evolution of a giant
body size (supplementary fig. S12).
Discussion
Despite intrinsic constraints on the evolution of large bodies,
mammalian species in multiple lineages have achieved dra-
matic body size changes through accelerated rates of
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phenotypic evolution (McNeill Alexander 1998; Baker et al.
2015). The evolution of gigantism can therefore shed light on
how biological systems can break underlying constraints, and
mitigate or overcome the evolutionary effects of tradeoffs on
whole-organism performance and survival (Kavanagh 2003;
Lailvaux and Husak 2014). The genome of the capybara, the
world’s largest rodent, is therefore crucial to addressing these
questions. Our analyses revealed insights into the capybara’s
particular morphology, offering the first genomic view of the
developmental regulators likely associated with the evolution
of a large body size (fig. 5). We identified several genes (and
gene families) under positive selection (and expanded) be-
longing to the IIS and TGFbS pathways, involved in cell pro-
liferation, postnatal bone growth, and the development of
musculoskeletal structures, which are relevant to the anatom-
ical and developmental modifications required for an increase
in overall body size. Our results suggest that gigantism in the
capybara could have been driven by a prolonged or faster
postnatal bone growth period, providing a possible case of
size increase driven by heterochrony consistent with obser-
vations in other giant species (e.g., Erickson et al. 2004).
Moreover, the IIS pathway has also been linked to rapid
and extreme body size evolution in the sunfish (Mola
mola), the world’s largest extant bony fish (Pan et al. 2016),
and to extreme size differences in dog breeds (Sutter et al.
2007), which could suggest a common genetic and develop-
mental pathway controlling rapid body size evolution
through cell proliferation in vertebrates.
Because there is no genome assembly yet available for rock
cavies (Kerodon sp.), the closest living relatives to the capy-
bara (supplementary fig. S5; together comprising the subfam-
ily Hydrochoerinae), one caveat of our analysis is that we
FIG. 5. Signaling pathways and mechanisms involved in body size and growth. IIS: PDX1, INS, LEP, IGFII, INSR, LEPR, PI3K, PRKCI, and PLAGL2;
TGFbS: BMPs, ACVR1B, BMPR1A, SMAD6, and R-Smads. TAPT1, MEOX2, and DEAF1 function during axial skeletal patterning. Solid arrows
indicate known and/or direct interactions; dashed arrows indicate unknown direct/indirect interaction. Figure is designed in BioRender.
A B
FIG. 6. Growth pathways are directly linked to cancer pathways. (A) Gene interaction network of capybara genes. Molecular interactions among 90
genes identified by the intersection of four criteria: lineage-specific family expansions, positive selection, rapid protein evolution, and unique
amino acid substitutions at sites otherwise fixed in rodents. Cluster analysis was based on Gene Ontology categories. (B) Intragenomic conflict
during the evolution of gigantism. Molecular interactions among 22 major genes involved in growth regulation by the IIS and TGFbS pathways, and
T-cell-mediated immune response. Eight of the 11 genes within the growth regulating pathways act also as oncogenes and are involved in known
cancer pathways.
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cannot identify changes specific to the capybara lineage after
splitting from Kerodon. Therefore, the genetic changes iden-
tified here could correspond to a recent common ancestor of
both hydrochoerine genera, but we note that capybaras are
still 60 times more massive than rock cavies, and rock cavies
are similar in size to guinea pigs. Future comparative analyses
including a genome from at least one of the two living species
of rock cavies would help further narrow the changes specific
to the capybara lineage. Additionally, we note that some
studies have shown that genomic scans of positive selection
based on branch-site tests and GO enrichment have the po-
tential to be misleading (e.g., Pavlidis et al. 2012; Venkat et al.
2018); however, several genes we identified show aberrant
phenotypes in mutant mice related to embryo size, postnatal
growth, axial skeletal patterning, and/or limb development
according to the Mouse Genome Informatics (MGI) database
(http://www.informatics.jax.org, last accessed October 5,
2020). Our results aim to identify potentially interesting can-
didate genes that could be further experimentally evaluated.
We also found genomic signatures related to the collateral
effects of evolving a large body size. For instance, our analyses
suggest that the capybara has a lower genome-wide synony-
mous substitution rate (dS), relative to the median value for
the entire Rodentia clade, consistent with a GTE. Also, the
capybara has a genome-wide nonsynonymous substitution
rate similar to the average for the clade, suggesting an ele-
vated number of fixed slightly deleterious mutations relative
to the mutational input (assuming dS as a surrogate for the
mutation rate). These results appear to be consistent with the
negative correlation between generation time and population
size (Chao and Carr 1993), and the accumulation of slightly
deleterious mutations caused by a reduction in Ne (Lynch and
Gabriel 1990; Lohr and Haag 2015). We must caution, how-
ever, that x values can be overestimated if polymorphic sites
are counted as divergence when only one sequence per spe-
cies is used to compute the substitution rates (Bierne and
Eyre-Walker 2004). Thus, future analyses would require ex-
plicit population data to better address the evolutionary con-
sequences of a large body size on genome evolution and
mutation load.
Finally, cancer imposes a strong constraint on morpholog-
ical and ontogenetic evolution (Kavanagh 2003), particularly
during the evolution of gigantism. The dual nature of growth
factors can create a scenario for an intragenomic conflict in
large-sized organisms, where somatic evolution leading to gi-
gantism may promote tumorigenic cells (Summers et al. 2002;
Wang et al. 2019). Cancers are selfish cell lineages that evolve
through somatic mutation and cell-lineage selection (Burt
and Trivers 2006). Thus, selection for large body size achieved
through greater cell proliferation can favor mutations that
also confer cellular autonomy in growth signals enhancing
their own probability of replication and transmission, a hall-
mark of cancer (Hanahan and Weinberg 2000; Summers et al.
2002); in fact, within species the risk of cancer scales positively
with body size (Tjalma 1966; Fraumeni 1967; Caulin and
Maley 2011). In line with this, our comparative genomic
results revealed that the evolution of a giant body size along
the hydrochoerine lineage likely involved selection on genes
and pathways that are directly linked to cancer (fig. 6B), con-
sistent also with recent findings showing that the develop-
ment of fast-growing antlers in ruminants involve the
expression of genes related to bone cancer (Wang et al.
2019). We hypothesize that the opportunity for selfish cell
lineages to arise, incidental to selection for cell proliferation,
imposes a selection pressure for cancer surveillance mecha-
nisms, generating a coupled evolution between growth-
promoting and tumor-suppression pathways, a plausible un-
derlying process causing Peto’s Paradox and a possible expla-
nation for how giant bodies can evolve in the first place (see
also Wang et al. 2019). Therefore, based on our analyses, we
propose a model for the evolution of gigantism in the capy-
bara, and the resolution of the conflict: somatic evolution
promoted by the IIS and TGFbS pathways through cell pro-
liferation allowed a phyletic increase in size, and the evolution
of T-cell-mediated tumor suppression pathway evolved as a
mechanism to counteract the increased cancer risk. Future




All procedures involving live animals followed protocols ap-
proved by the Comite Institucional de Uso y Cuidado de
Animales de Laboratorio (CICUAL) of the Universidad de
los Andes, approval number C.FUA_14-023, June 5, 2014.
Research and field collection of samples was authorized by
the Autoridad Nacional de Licencias Ambientales (ANLA) de
Colombia under the permiso marco resolucion No. 1177 to the
Universidad de los Andes.
Capybara Genome Sequencing and Assembly
As part of the 200 Mammalian Genomes project, the
SciLifeLab at Uppsala University and the Broad Institute se-
quenced and assembled a DISCOVAR de novo genome as-
sembly (Weisenfeld et al. 2014) from a sample of a wild-born
female H. hydrochaeris from the San Diego Zoo’s Frozen Zoo
(frozen sample KB10393), imported from Paraguay. The ge-
nome assembly was performed with the DISCOVAR de novo
pipeline, generating an assembly spanning 2.734 Gb with a
scaffold N50 length of 0.202 Mb (table 1).
The Dovetail Genomics proprietary scaffolding method
based on Chicago libraries (Putnam et al. 2016) was used to
upgrade the initial DISCOVAR assembly. Dovetail’s novel ap-
proach to increasing the contiguity of genome assemblies
combines initial short-read assemblies with long-range infor-
mation generated by in vitro proximity ligation of DNA in
chromatin. From the same individual of H. hydrochaeris used
to obtain the initial DISCOVAR de novo assembly, 500 ng of
high molecular weight gDNA (50 kb mean fragment size) was
used as input for the Chicago libraries. The libraries were
sequenced on two lanes of an Illumina HiSeq in Rapid Run
Mode to produce 316 million 2  100 bp paired-end reads,
which provided 67 physical coverage (measured in bins of
1–50 kb).
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The reads were assembled by Dovetail Genomics using the
HiRise Scaffolder pipeline and the DISCOVAR de novo ge-
nome assembly as inputs. Shotgun and Chicago library
sequences were aligned to the draft input assembly using a
modified SNAP read mapper (http://snap.cs.berkeley.edu) to
generate an assembly spanning 2.737 Gb, with a contig N50
length of 161.1 kb and an impressive scaffold N50 length of
12.2 Mb, as calculated using the QUAST software (Gurevich
et al. 2013).
Assembly Quality and Annotation
Two approaches were employed to evaluate the quality of the
assembly: 1) The Core Eukaryotic Genes Mapping Approach
(Parra et al. 2007) was used to determine the number of
complete core eukaryotic genes recovered, and 2) an analysis
of BUSCOs (Sim~ao et al. 2015) was applied as an evolutionary
measure of genome completeness, using the vertebrate data
set (3,023 genes) as query. Gene content of a well-assembled
genome should include a high proportion (75%) of both
core eukaryotic genes and BUSCOs (supplementary fig. S1,
Supplementary Material online).
Putative genes were located in the assembly by homology-
based annotation with MAKER v2.31.9 (Cantarel et al. 2007)
based on protein evidence from mouse (Mus musculus), rat
(Rattus norvegicus), and guinea pig (Cavia porcellus; Ensembl
release 85). CD-HIT v4.6.1 (Li et al. 2001) was used to cluster
highly homologous protein sequences across the three pro-
tein sets and generate a nonredundant protein database
(nrPD), which was used to guide gene predictions on the
capybara genome. To evaluate the quality of the annotations,
the AED score was used as a measure of congruence between
each annotation and the homology-based evidence (in this
case, protein sequences). When an annotation perfectly
matches the overlapping model protein, the AED value is 0
(Yandell and Ence 2012). As a rule of thumb, a genome an-
notation where 90% of the annotations have an AED less than
0.5 is considered well annotated (Campbell et al. 2014). The
capybara genome annotation has 92.5% of its annotations
with an AED below 0.5.
PANTHER (Thomas et al. 2003) was used to characterize
the functions of the capybara-annotated proteins (supple-
mentary fig. S2, Supplementary Material online). PANTHER
is a library of protein families and subfamilies that uses the
GO database to assign function to proteins. Following the
protocol for large-scale gene function analysis with PANTHER
(Mi et al. 2013), the Scoring Tool was used to assign each
protein of the capybara genome to a specific protein family
(and subfamily) based on a library of hidden Markov models.
Annotation of Repeat Elements
RepeatMasker open-4.0.5 (Smit et al. 2013) was used to iden-
tify and classify transposable elements and short tandem
repeats by aligning the capybara genome sequences against
a reference library of known repeats for rodents, using default
parameters. For comparison, NCBI annotation releases for 13
additional rodents were used (fig. 1).
Analysis of Substitution Rate Variation among Rodent
Genomes
In order to estimate the mutation load, we used the ratio of
the rates of nonsynonymous substitutions over synonymous
substitutions (dN/dS or x) as a proxy. A set of 229 SCOs
shared across the 16 rodent genomes (supplementary table
S3, Supplementary Material online) was recovered with the
software Proteinortho (Lechner et al. 2011). Values of x were
estimated for the set of 229 SCOs, using the program
CODEML from the PAML package v4.8 (Yang 2007). Two
evolutionary models were evaluated: model 0 with x held
constant over the time-calibrated concatenated likelihood
tree, and model 1 with free x estimated separately for each
branch. Likelihood-ratio tests were used to compare the two
models, and in each case the model 1 was the preferred one.
Only x values associated with external branches were used as
measures of mutation load. Codon-based alignments were
performed with MACSE (Ranwez et al. 2011) with default
parameters and poorly aligned regions were trimmed with
Gblocks v. 0.91 b (Talavera and Castresana 2007). To deter-
mine whether the capybara has a higher genome-wide me-
dian x relative to other rodents, a permutation test (1,000
permutations) on each substitution rate (dN, dS, x) was per-
formed to create a null distribution of the differences of (me-
dian capybara  median rodents), and then compared with
the observed values.
The correlations between median genome-wide x versus
body mass (and generation time) were evaluated using phy-
logenetic independent contrasts (Felsenstein 1985) to control
for the potentially confounding effects of shared evolutionary
history. Values of adult body mass and generation time were
obtained from AnAge database (Tacutu et al. 2012). Because
for most mammalian species comparable genetic estimates of
nuclear Ne were not available, we used body mass as a proxy
for Ne. Median genome-wide x values per species and natural
log-transformed values of body mass were used to estimate
the impact of the reduction of effective population size on
the strength of purifying selection. Assessment of linear
model assumptions was performed with the gvlma R package
(R Development Core Team 2011).
Gene Family Composition
To search for expanded gene families in the capybara, we
performed gene family assignments for each of the 16 rodent
genomes (supplementary table S3, Supplementary Material
online) using the protocol for large-scale gene function anal-
ysis with PANTHER (Mi et al. 2013). Following Simakov et al.
(2013), functional repertoires of the genomes were repre-
sented in a multidimensional space, where each dimension
corresponds to a particular gene family. A PCA was con-
ducted using the prcomp function in R (R Development
Core Team 2011) on the count of the number of genes in
each gene family as identified by PANTHER. The coordinate
of a species’ genome along each dimension represents the
number of genes that it contains with the corresponding
gene family normalized by the total number of genes in
that particular species. PCA based on content and size of
gene families has been shown to reflect important
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evolutionary splits between groups or clades of animals (non-
bilaterian and bilaterian: Simakov et al. 2013; deuterostomes
and protostomes: Albertin et al. 2015). In rodents, PC1 com-
ponent separated the capybara from all other rodent
genomes and explained 20.14% of variance, whereas PC2
grouped all genomes and explained 11.34% of the variance.
An overrepresentation test was conducted on the gene fam-
ilies that fell on both 2.5% tails of the loadings of PC1 and PC2
to determine the gene families that dominate the loadings of
each principal component. A Fisher’s exact test was then
performed iteratively in R (R Development Core Team
2013) on counts of each PANTHER gene family from the
5% tails of PC1 and PC2 against the complete set of gene
families (23,110 families). To be defined as enriched, we as-
sumed a significance level a¼ 0.05 for each gene family, be-
fore a traditional Bonferroni correction for multiple testing.
To conduct a genome-wide screen for gene family expan-
sions, a table with 14,825 shared PANTHER gene families,
present in at least 15 of the 16 genomes, was constructed
with the counts for genes annotated to those families in the
16 rodent genomes (see above). A Fisher’s exact test was then
performed iteratively in R (R Development Core Team 2011)
comparing the number of genes found in the capybara in
each gene family against the total number of genes in the
remaining 15 rodents for a given gene family. To be defined as
enriched, a gene family had to have a significant P-value
(a< 0.05) after a traditional Bonferroni correction for multi-
ple testing. We calculated a Z-score per gene family per spe-
cies, where 1) the individual counts of each gene family per
species were normalized by the total number of genes in the
genome of each species and 2) the normalized counts were
standardized within each gene family (across species) with the
scale function in R (R Development Core Team 2011) and
visualized as a heatmap (fig. 4B, supplementary fig. S8,
Supplementary Material online). This Z-score represented
the number of standard deviations below or above the
mean gene family count for each species.
Positive Selection Analysis Using Codon-Based Models
of Evolution
Amino acid sites within a protein may experience different
selective pressures and have different underlying x ratios
(Yang and Bielawski 2000). We fitted branch-site models to
identify positive selection in a set of 4,452 SCOs obtained
using the OrthoVenn software (Wang et al. 2015) on capy-
bara versus four closely related rodents with published whole-
genome sequences: naked mole rat, degu, chinchilla, and
guinea pig. Codon-based alignments were performed with
MACSE (Ranwez et al. 2011) with default parameters and
poorly aligned regions were trimmed with Gblocks v. 0.91b
(Talavera and Castresana 2007). Downstream analyses of se-
lective pressure variation were done using the Selection
Analysis Preparation functions provided in VESPA v1.0b
(Webb et al. 2016). We compared the likelihood scores of
two branch-site selection models using likelihood-ratio tests
as a measure of model fit: 1) model A implemented in
CODEML in the PAML package v4.8 (Yang 2007), which
attempts to detect positive selection acting on a few sites
on specified lineages or “foreground branches” (x > 1), ver-
sus the null model (A null) in which codons can only evolve
neutrally (x ¼ 1) or under purifying selection (0 < x < 1;
Zhang et al. 2005); and 2) an adaptive branch-site random
effects model (aBSREL) implemented in the HyPhy package
(Smith et al. 2015) (see Supplementary Material online for the
comparison between both models).
As maximum likelihood methods to detect positive selec-
tion are sensitive to sample size (Anisimova et al. 2002), in-
creasing the possibility of false positives (Zhang 2004), we
calculated a second measure of rapid evolution of each
gene: ((Capybara, guinea pig), degu) protein trios were used
to estimate the difference of the raw p-distance in protein
sequence between capybara and degu (pdCD), and the raw p-
distance between guinea pig and degu (pdGD). These two
distances were used to calculate the “protein distance index”
or PDI for each i gene (PDIi¼ pdCDi pdGDi) which takes a
value of zero if the two p-distances are equal, meaning that
the capybara and guinea pig lineages have evolved at equal
rates since their divergence from their MRCA. A standardized
PDI was calculated by dividing the PDI value by the pdGD to
account for different rates of evolution between proteins. A
positive value is indicative of accelerated protein evolution in
the capybara lineage. We considered genes in the top 5% of
the distribution in both dimensions (i.e., the LRs of branch-
site models and the standardized PDI statistic) as positively
selected in the capybara lineage. LRs from both models
(model A and aBSREL) were strongly correlated (Wilcoxon
signed-rank test, W¼ 10,429,750, P-value < 0.001) and
resulted in the same set of outlier genes when combined
with the PDI statistic (supplementary fig. S13,
Supplementary Material online) so only model A results
from CODEML were used in further analyses.
For genes exhibiting signatures of lineage-specific positive
selection, we conducted a GO enrichment analysis to identify
GO categories overrepresented in these genes relative to the
4,452 SCO set. The GO categories for each gene were re-
trieved with the biomaRt R package (Durinck et al. 2009)
using the protein stable IDs of guinea pig orthologs. A
Fisher’s exact test was then performed iteratively in R (R
Development Core Team 2011) on counts of each
Biological Process from the positively selected genes against
the full set of orthologs (4,452 genes). To be defined as
enriched, a GO category had to have a significant P-value
(a< 0.05) after a traditional Bonferroni correction for multi-
ple testing. TreeMap of GO biological process terms that are
overrepresented in genes evolving under positive selection in
the capybara relative to the mouse was drawn using REVIGO
(Supek et al. 2011).
Gene Interaction Network Analyses
We generated a list of 195 candidate genes that showed
lineage-specific positive selection, pairwise x > 1, rapid evo-
lution (top 1%), high concentration of capybara-unique res-
idues (top 5%), and gene-family expansions specific to the
capybara. Insulin was included as part of the 195 gene set
given that previous analyses showed signatures of adaptive
evolution among Caviomorph rodents (Opazo et al. 2005). Of
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the 195 genes, only 90 genes presented known or predicted
interactions with each other according to String Database
(Mering et al. 2003). We used this new gene set to perform
a network analysis of GO Biological Processes and KEGG
pathways on the 90 interacting genes. Networks were con-
structed based on String DB interactions and plotted with
Cytoscape 3.0 (Shannon et al. 2003). GO and KEGG enrich-
ment analyses were performed based on String DB informa-
tion with a false discovery rate of 0.05.
Supplementary Material
Supplementary data are available at Molecular Biology and
Evolution online.
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